Not exact matches
Gemcitabine is used to
treat patients with pancreatic, lung, breast and
bladder cancers.
Radiation therapy used to
treat uterine
cancer may increase a
patient's risk of developing
bladder cancer.
It is commonly thought that
bladder cancers that develop after pelvic radiation tend to be aggressive, with high grades and stages, but this study found that the types, grades, and stages of
bladder cancer that developed were similar in
patients treated with and without radiation therapy.
With an average follow - up of 15 years,
bladder cancer incidence in uterine
cancer patients treated with pelvic radiation therapy was twice as high as that seen in
patients treated without radiation.
In a study involving 12
patients with
bladder cancer, who also underwent prostate surgery as part of their treatment, she identified the ICOS molecule as the first immunologic marker identified in both tumor tissues and the systemic circulation that can be used as a biomarker for monitoring of anti-CTLA-4
treated patients as a possible marker of therapeutic activity.